ALXO - Alx Oncology Holdings Inc
2.15
0.110 5.116%
Share volume: 334,648
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.04
0.11
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 11-07-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 37.762 M | 41.525 M | 32.567 M | 30.613 M | 31.820 M | 22.532 M | |
| Selling general and admin | 6.045 M | 6.872 M | 6.096 M | 7.081 M | 7.932 M | 5.091 M | |
| Research and development | 31.717 M | 34.653 M | 26.471 M | 23.532 M | 23.888 M | 17.441 M | |
| Total expenses | 37.762 M | 41.525 M | 32.567 M | 30.613 M | 31.820 M | 22.532 M | |
| 9.97% | -21.57% | -6.00% | 3.94% | -29.19% | |||
| Operating income | -37.762 M | -41.525 M | -32.567 M | -30.613 M | -31.820 M | -22.532 M | |
| Ebit | -37.776 M | -41.533 M | -32.564 M | -30.614 M | -31.831 M | -22.538 M | |
| Pretax income | -35.581 M | -39.399 M | -30.707 M | -29.163 M | -30.754 M | -22.144 M | |
| 10.73% | -22.06% | -5.03% | 5.46% | -28.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -35.581 M | -39.399 M | -30.707 M | -29.163 M | -30.754 M | -22.144 M | |
| -10.73% | 22.06% | 5.03% | -5.46% | 28.00% |